Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Pharma
Pfizer charges $3.5M for its first FDA-approved gene therapy
Pfizer has gained its first FDA approval for a gene therapy, scoring with Beqvez for hemophilia B and will charge $3.5M for the one-time therapy.
Kevin Dunleavy
Apr 26, 2024 10:19am
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel
Apr 23, 2024 11:16am
Kyowa's Orchard hopes $4.25M gene therapy price tag bears fruit
Mar 20, 2024 10:40am
Orchard nabs approval for first MLD gene therapy in US
Mar 18, 2024 3:25pm
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
Mar 15, 2024 10:15am
Takeda to lay off 190 Austrian workers after gene therapy pivot
Mar 13, 2024 10:15am